for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cyclacel Pharmaceuticals Inc

CYCC.OQ

Latest Trade

0.45USD

Change

0.00(0.00%)

Volume

56,927

Today's Range

0.44

 - 

0.50

52 Week Range

0.28

 - 

1.18

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Cyclacel Pharmaceuticals Reports Third Quarter Results

Nov 13 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.CYCLACEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.11.CYCLACEL PHARMACEUTICALS INC - AS OF SEPTEMBER 30, 2019, CASH AND CASH EQUIVALENTS TOTALED $13.0 MILLION.

Cyclacel Pharmaceuticals Announces Qtrly Loss Per Share $0.11

Aug 13 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.CYCLACEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.11.

Cyclacel Pharmaceuticals Inc Files For Mixed Shelf Of Upto $100 Million

June 3 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS INC FILES FOR MIXED SHELF OF UPTO $100 MILLION - SEC FILING.

Cyclacel Pharmaceuticals Reports Qtrly Net Loss Per Share $0.12

May 14 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.CYCLACEL PHARMACEUTICALS INC - AS OF MARCH 31, 2019, CASH AND CASH EQUIVALENTS TOTALED $17.9 MILLION COMPARED TO $17.5 MILLION AS OF DECEMBER 31, 2018.CYCLACEL PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS ENDED MARCH 31, 2019 WAS $1.8 MILLION COMPARED TO $1.3 MILLION FOR SAME PERIOD IN 2018.CYCLACEL PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE $0.12.

Cyclacel Pharmaceuticals Reports Q4, FY18 Results

March 27 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.

Cyclacel Pharmaceuticals Inc says No Assurance That Future Quarterly Dividends Will Be Declared

March 12 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS INC - NO ASSURANCE THAT FUTURE QUARTERLY DIVIDENDS WILL BE DECLARED.

Cyclacel Pharmaceuticals - Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq Stock Market LLC

Jan 11 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS - ON JAN 8, GOT NOTICE OF DELISTING OR FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD FROM NASDAQ STOCK MARKET LLC.CYCLACEL PHARMACEUTICALS - INTENDS TO CONSIDER AVAILABLE OPTIONS TO RESOLVE NONCOMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT - SEC FILING.

Cyclacel Pharmaceuticals Says Approved Renewal Of Employment Agreements Of CEO Spiro Rombotis, CFO Paul Mcbarron

Jan 7 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS - APPROVED RENEWAL OF EMPLOYMENT AGREEMENTS OF CEO SPIRO ROMBOTIS, CFO PAUL MCBARRON.CYCLACEL PHARMACEUTICALS - EMPLOYMENT RENEWALS TO BE EFFECTIVE FROM JANUARY 1, 2019 THROUGH JANUARY 1, 2021 - SEC FILING.

Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 12 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.QTRLY LOSS PER SHARE $0.91.Q3 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S.CYCLACEL PHARMACEUTICALS - ESTIMATE THAT CASH RESOURCES WILL BE SUFFICIENT TO FUND OPERATIONS UNTIL Q2 OF 2020.

Cyclacel Pharmaceuticals Says Entered Into A Common Stock Sales With H.C. Wainwright & Co, In Connection With An At Market Offering

Oct 4 (Reuters) - Cyclacel Pharmaceuticals Inc <CYCC.O>::CYCLACEL PHARMACEUTICALS - ENTERED INTO A COMMON STOCK SALES WITH H.C. WAINWRIGHT & CO, IN CONNECTION WITH AN AT MARKET OFFERING - SEC FILING.CYCLACEL PHARMACEUTICALS INC - AS PER ATM OFFERING, CO MAY OFFER AND SELL SHARES, PAR VALUE $0.001 PER SHARE, HAVING OFFERING PRICE OF UP TO $5 MILLION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up